Tag: biotech stocks

The Nasdaq Biotechnology ETF (NASDAQ:IBB) saw a knee-jerk reaction lower Wednesday after President-elect Donald Trump made harsh comments about drug pricing. On Wednesday, it finished off by -2.99%. While that...

When this market cycle finally comes to an end, among the sectors that will be remembered as one of its key drivers is biotechnology....

About $7 ago, I tweeted that Gilead Sciences stock (NASDAQ:GILD) was starting to present a real conundrum of fundamentals/valuation (positive) vs. technicals (negative). So...

The Biotech Sector (NASDAQ:IBB) has been volatile the last few weeks, more so than the market at least with two opposing forces. On one...

Are we really talking about a biotech sector breakout? Biotech stocks have been through a lot in the last 12 months... The biotech sector as...

A key index of biotechnology stocks may be approaching significant levels of resistance. Throughout the course of the post-February rally, one topic that has been...

Here's a breathtaking fact: The IBB (Biotech Index) went down 33% from peak to trough during the "Great Recession." The IBB is now down...

When we last wrote about XBI, the S&P Biotech Sector Fund ETF, we noted that it appeared ready for a countertrend rally. In the...

Biotech was a sector that was a notable laggard in Q1 with the Nasdaq Biotech Sector ETF (IBB) down nearly 24% and S&P Biotech...

Over two weeks ago, we shared our thoughts on why the S&P Biotech Sector ETF (symbol XBI) might be nearing a tradable bottom. In...